Medical device company developing DVTect, an easy early test for deep vein thrombosis
Kynetyka Technologies is a privately held Australian medical device company headquartered in Adelaide that is developing and commercialising DVTect, a non-invasive point-of-care screening test for deep vein thrombosis. On 1 October 2026 it announced $795,000 in non-dilutive funding through AUScelerate's Targeted Translation Research Accelerator program, supported by the Medical Research Future Fund, toward a $1.2 million DVTect project.
For people
For agents
Nothing listed yet.